In ZINC since | Heavy atoms | Benign functionality |
---|---|---|
May 2nd, 2006 | 32 | No |
Popular Name: 4-hydroxy-3,5-dimethoxybenzaldehyde [4,6-di(1-piperidinyl)-1,3,5-triazin-2-yl]hydrazone 4-hydroxy-3,5-dimethoxybenzaldeh…
Type pH range | xlogP | Des A‑Pol Apolar desolvation (kcal/mol) | Des Pol Polar desolvation (kcal/mol) | H Don H-bond donors | H Acc H-bond acceptors | Chg Net charge | tPSA (Ų) | MWT Molecular weight (g/mol) | RB Rotatable bonds | DL |
---|---|---|---|---|---|---|---|---|---|---|
Ref Reference (pH 7) | 4.01 | -5.76 | -13.43 | 2 | 10 | 0 | 108 | 441.536 | 7 | ↓ |
Code | Description | Organism Class | Affinity (nM) | LE (kcal/mol/atom) | Type |
---|---|---|---|---|---|
MTOR-3-E | Serine/threonine-protein Kinase MTOR (cluster #3 Of 3), Eukaryotic | Eukaryotes | 5900 | 0.23 | Binding ≤ 10μM |
Uniprot | Swissprot | Description | Affinity (nM) | LE (kcal/mol/atom) | Type |
---|---|---|---|---|---|
MTOR_HUMAN | P42345 | FK506 Binding Protein 12, Human | 5900 | 0.23 | Binding ≤ 10μM |
Description | Species |
---|---|
CD28 dependent PI3K/Akt signaling | |
Constitutive PI3K/AKT Signaling in Cancer | |
HSF1-dependent transactivation | |
mTOR signalling | |
PIP3 activates AKT signaling | |
Release of eIF4E | |
S6K1-mediated signalling | |
VEGFR2 mediated vascular permeability |